However, gel shift assays revealed an increase in Sp1 and Sp2 binding compared to sensitive cells in methotrexate-resistant HT29 human colon cancer cells, without differences in the Sp1 protein levels [20]. The gene discussed is SP1; the disease is malignant colon neoplasm.